Building on a legacy in eye care.

ALLERGAN IS NOW ABBVIE.

As AbbVie, our commitment to protect and preserve vision remains the same both through our current portfolio of eye care products across glaucoma, ocular surface disease and retinal diseases, and through our commitment to innovation and addressing unmet needs with our diverse R&D pipeline.

Allergan’s rich heritage in eye care combined with the global scale of AbbVie means greater reach and more resources for innovation, so we can continue our relentless search for new and better eye care treatments for more patients around the world.